Socioeconomic and racial disparities are linked in the severity and treatment of lupus.
Ultrasound imaging is more accurate, faster, and less painful than traditional X-rays for assessing the broken arms of children.
Compete against your peers with our rheumatoid arthritis clinical quiz.
Ankylosing Spondylitis and Axial Spondyloarthritis Treatment Recommendations: A Clinical Practice Assessment
Compete against your peers with our ankylosing spondylitis/nonradiographic axial spondyloarthritis clinical quiz.
The effects of alcohol on the body's systems are examined here, with both damaging and potentially protective effects being explored.
While studies on the effect of the gut microbiome on spondyloarthritis are limited, new research and technology are poised to expand future microbiome-directed arthritis treatments.
Patients with rheumatoid arthritis have an increased risk of developing cardiovascular disease (CVD) and CVD-related mortality compared with the general population. Despite the growing recognition of CVD as a common complication of RA, many rheumatologists do not aggressively manage CV risk in patients with rheumatic disease.
Lorraine Fitzpatrick, MD, discusses updated results from the ACTIVE phase 3 clinical trial.
Dinesh Khanna, MD, MSc, discusses results of the open-label portion of a trial evaluating the safety and efficacy of placebo-treated patients with systemic sclerosis who were switched to received open-label tocilizumab.
John H. Stone, MD, MPH, discusses results from a phase 3, double-blind, randomized, controlled trial evaluating the efficacy of tocilizumab for the treatment of giant cell arteritis.
Gerd Burmester, MD,discusses results from the SARIL-RA-MONARCH trial.
Sarah Taber, MD, briefly reviews her ongoing research on genetic drivers of localized scleroderma in pediatric patients.
Kenneth Saag, MD, discusses new pooled safety data for lesinurad for the treatment of gout.
Researchers suggest that relapsing MPA and GPA and increased BMI were associated with increased glucocorticoid exposure following induction of remission.
Eric L. Matteson, MD, MPH, sat down with Rheumatology Advisor to discuss the morbidity associated with interstitial lung disease in RA.
Nancy E. Lane, MD, professor of medicine, at the University of California at Davis School of Medicine, discusses results from the phase 3 ACTIVE trial.
Patient-reported outcomes have become a very important way to gain insight into outcomes of disease.
Mary K. Crow, MD, discusses upcoming presentations at the ACR annual conference to be held November 11 - 16, in Washington, DC.
Rheumatology Advisor Articles
- FDA Clears Radiofrequency Treatment for Osteoarthritis Knee Pain
- Osteoporosis Treatment Receives Updated Guidelines From ACP
- Six Institutional Areas Tied to Physician Burnout
- Assessing the Diagnostic Accuracy of MRI in Early Rheumatoid Arthritis
- Superior Reduction in Osteoarthritis Knee Pain From Novel Hyaluronan Injection
- Knee Osteoarthritis: Intra-Articular Triamcinolone vs Saline Injection
- Knee Pain Relief From Fiber, Chondroitin in Osteoarthritis
- Bone Mineral Density Changes Related to Adrenal Incidentalomas in Menopause
- Patients Satisfied With Telemedicine Primary Care Visits
- HIV-Induced Osteoporosis Detected Via Bone Ultrasonography